Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. liver functions
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Date

  • Older

Liver Functions Articles & Analysis

11 news found

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained a solid reputation. Recently, Creative Enzymes launched a variety of ...

ByCreative Enzymes


New independent market research says 84% US healthcare professionals likely to use Orviglance imaging agent in target population

New independent market research says 84% US healthcare professionals likely to use Orviglance imaging agent in target population

Ascelia Pharma today announced and welcomed the results of independent market research showing that 84% of healthcare professionals will likely use Orviglance for magnetic resonance imaging (MRI) in patients with cancer in the liver and reduced kidney function. The independently conducted survey asked 270 healthcare professionals in the US (radiologists, oncologists and nephrologists) about ...

ByAscelia Pharma AB


Primary Results of Onawa (Solti-1802) Trial: A Window Of Opportunity Trial Of Onapristone In Postmenopausal Women With Progesterone Receptor-Positive/Her2-Negative Early Breast Cancer

Primary Results of Onawa (Solti-1802) Trial: A Window Of Opportunity Trial Of Onapristone In Postmenopausal Women With Progesterone Receptor-Positive/Her2-Negative Early Breast Cancer

PGR is an estrogen-responsive gene and progesterone receptor (PR) expression, evaluated by immunohistochemistry (IHC), is used as a clinical biomarker of estrogen signaling and estrogen receptor (ER) functionality.1 Despite the well-studied role of PGR as mitogen and independent ER activator, anti-progestins for the treatment of BC have been poorly tested. While limited success for ...

ByContext Therapeutics Inc.


Health & Wellness: What Urinalysis Could Say About Your Well-being

Health & Wellness: What Urinalysis Could Say About Your Well-being

Most people would agree that only looking at your bank account once a year is a bad idea, yet when we look at our own health, the only data many of us collect is from a once-a-year checkup, in which doctors will run a series of laboratory tests. These tests are a single data point describing the very dynamic systems that are our bodies, which change throughout the year. In order to start ...

ByFluxergy


Canadian Ambassador to China Dominic Barton visited SWS Medical

Canadian Ambassador to China Dominic Barton visited SWS Medical

On May 31, 2021, Mr. Dominic Barton, Canadian Ambassador to China, accompanied by Consul General Jeff David and trade commissioners from the Canadian Consulate General in Chongqing, visited SWS ...

BySWS Hemodialysis Care Co., Ltd.


HistoSonics Announces Milestone as AMA Issues Unique Category III CPT Code for Histotripsy of Liver

HistoSonics Announces Milestone as AMA Issues Unique Category III CPT Code for Histotripsy of Liver

HistoSonics is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for histotripsy of the liver. Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy tissue in the liver without incisions, ionizing radiation or heat. The new CPT code will become ...

ByHistoSonics


HistoSonics Announces First Patient Treated in European Clinical Trial

HistoSonics Announces First Patient Treated in European Clinical Trial

HistoSonics announced today that the first patient has been treated as part of the company’s #HOPE4LIVER Europe Trial, which was approved by German authorities earlier in the year. The study is designed to evaluate the safety and efficacy of the HistoSonics’ platform technology, which uses the novel science of histotripsy and the mechanical properties of therapeutic focused ...

ByHistoSonics


HistoSonics Announces First Patient Treated in US Clinical Study of Novel Sonic Beam Therapy for Liver Tumors

HistoSonics Announces First Patient Treated in US Clinical Study of Novel Sonic Beam Therapy for Liver Tumors

HistoSonics announced today the treatment of the first patient in the #HOPE4LIVER US Study. The investigational device study was approved by the FDA in the fourth quarter of 2020. The study is designed to evaluate the safety and efficacy of the company’s platform technology, which uses the novel science of histotripsy, a form of therapeutic focused ultrasound, to mechanically destroy ...

ByHistoSonics


Newly Discovered Cells Restore Liver Damage in Mice without Cancer Risk

The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the National Institutes of Health discovered a type of cell in mice essential to the process. The researchers also found similar cells in humans. When healthy liver cells are depleted by long-term exposure to toxic ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Soap antimicrobial may damage liver and raise cancer risk, mouse study shows

Long-term exposure to triclosan, an antimicrobial agent commonly found in a broad array of soaps, shampoos, toothpastes and other consumer products, may have potentially serious health consequences, reports a research team including a UC Davis scientist. Data from a new study shows that triclosan causes liver fibrosis and cancer in laboratory mice through molecular mechanisms that are also ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease, recognized by WHO as one of the world`s neglected tropical diseases

Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease, recognized by WHO as one of the world`s neglected tropical diseases

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT